1. Home
  2. BHVN vs MCRI Comparison

BHVN vs MCRI Comparison

Compare BHVN & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • MCRI
  • Stock Information
  • Founded
  • BHVN 2013
  • MCRI 1972
  • Country
  • BHVN United States
  • MCRI United States
  • Employees
  • BHVN N/A
  • MCRI N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • MCRI Hotels/Resorts
  • Sector
  • BHVN Health Care
  • MCRI Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • MCRI Nasdaq
  • Market Cap
  • BHVN 1.4B
  • MCRI 1.6B
  • IPO Year
  • BHVN 2017
  • MCRI 1993
  • Fundamental
  • Price
  • BHVN $13.50
  • MCRI $104.34
  • Analyst Decision
  • BHVN Strong Buy
  • MCRI Hold
  • Analyst Count
  • BHVN 14
  • MCRI 5
  • Target Price
  • BHVN $58.85
  • MCRI $96.20
  • AVG Volume (30 Days)
  • BHVN 1.6M
  • MCRI 177.7K
  • Earning Date
  • BHVN 08-07-2025
  • MCRI 07-16-2025
  • Dividend Yield
  • BHVN N/A
  • MCRI 1.15%
  • EPS Growth
  • BHVN N/A
  • MCRI N/A
  • EPS
  • BHVN N/A
  • MCRI 4.22
  • Revenue
  • BHVN N/A
  • MCRI $534,693,999.00
  • Revenue This Year
  • BHVN $3.00
  • MCRI $4.32
  • Revenue Next Year
  • BHVN $59.97
  • MCRI $2.41
  • P/E Ratio
  • BHVN N/A
  • MCRI $24.75
  • Revenue Growth
  • BHVN N/A
  • MCRI 4.65
  • 52 Week Low
  • BHVN $13.04
  • MCRI $67.14
  • 52 Week High
  • BHVN $55.70
  • MCRI $113.88
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 42.74
  • MCRI 71.62
  • Support Level
  • BHVN $13.30
  • MCRI $102.87
  • Resistance Level
  • BHVN $14.09
  • MCRI $108.52
  • Average True Range (ATR)
  • BHVN 0.82
  • MCRI 2.97
  • MACD
  • BHVN 0.05
  • MCRI 1.43
  • Stochastic Oscillator
  • BHVN 19.74
  • MCRI 66.19

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About MCRI Monarch Casino & Resort Inc.

Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.

Share on Social Networks: